{
"info": {
"nct_id": "NCT00784862",
"official_title": "A Randomised, Double Blind Trial to Assess the Pharmacokinetics of Arimidex Alone, Nolvadex Alone, or Arimidex and Nolvadex in Combination, When Used as Adjuvant Treatment for Breast Cancer in Postmenopausal Women",
"inclusion_criteria": "* Eligible for entry into the main ATAC trial 1033IL/0029\n* Patients must have been taking ATAC trial medication for at least 3 months (i.e. patients must have reached at least visit 2 of the main ATAC study)\n* Patients should be taking their medication in the mornings for at least 3 months\n* Patients must be 100% compliant over the preceding fourteen days\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 45 Years",
"exclusion_criteria": "* Excluded from entry into the main ATAC trial (1033IL/0029)\n* Patients whose concurrent treatment includes diazepam or drugs which might affect tamoxifen steady state levels or steroid hormone status. These include ketoconazole (antifungal) or related compounds",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Eligible for entry into the main ATAC trial 1033IL/0029",
"criterions": [
{
"exact_snippets": "Eligible for entry into the main ATAC trial 1033IL/0029",
"criterion": "eligibility for ATAC trial 1033IL/0029",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients must have been taking ATAC trial medication for at least 3 months (i.e. patients must have reached at least visit 2 of the main ATAC study)",
"criterions": [
{
"exact_snippets": "Patients must have been taking ATAC trial medication for at least 3 months",
"criterion": "ATAC trial medication duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
},
{
"exact_snippets": "patients must have reached at least visit 2 of the main ATAC study",
"criterion": "ATAC study visit",
"requirements": [
{
"requirement_type": "visit number",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "visit"
}
}
]
}
]
},
{
"line": "* Patients should be taking their medication in the mornings for at least 3 months",
"criterions": [
{
"exact_snippets": "Patients should be taking their medication in the mornings",
"criterion": "medication timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "mornings"
}
]
},
{
"exact_snippets": "for at least 3 months",
"criterion": "medication duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Patients must be 100% compliant over the preceding fourteen days",
"criterions": [
{
"exact_snippets": "Patients must be 100% compliant over the preceding fourteen days",
"criterion": "compliance",
"requirements": [
{
"requirement_type": "percentage",
"expected_value": {
"operator": "=",
"value": 100,
"unit": "%"
}
},
{
"requirement_type": "time period",
"expected_value": "preceding fourteen days"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 45 Years",
"criterions": [
{
"exact_snippets": "minimum age of 45 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 45,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Excluded from entry into the main ATAC trial (1033IL/0029)",
"criterions": [
{
"exact_snippets": "Excluded from entry into the main ATAC trial (1033IL/0029)",
"criterion": "entry into the main ATAC trial",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients whose concurrent treatment includes diazepam or drugs which might affect tamoxifen steady state levels or steroid hormone status. These include ketoconazole (antifungal) or related compounds",
"criterions": [
{
"exact_snippets": "concurrent treatment includes diazepam",
"criterion": "concurrent treatment with diazepam",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "drugs which might affect tamoxifen steady state levels",
"criterion": "drugs affecting tamoxifen steady state levels",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "drugs which might affect ... steroid hormone status",
"criterion": "drugs affecting steroid hormone status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "These include ketoconazole (antifungal) or related compounds",
"criterion": "treatment with ketoconazole or related compounds",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}